Evidence map›Paper›PMID 41380903›Full record

ArticleCancer letters2026

Fgl2-knockout tumor cells serve as a vaccine inducing long-duration brain-resident memory T cells that reject subsequent intracranial tumor cell challenges.

Sheng Zhang, Yining Jin, Zhiliang Jia, Xueqing Xia, Yang Li, Qi Wang, Jing Wang, Jian Wang, Joya Chandra, Gregory K Friedman and 1 more

Abstract read
In one paragraph

Article in Cancer letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sheng ZhangDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Yining JinDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Zhiliang JiaDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Xueqing XiaDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Yang LiDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Qi WangDepartment of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, USA.
Jing WangDepartment of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, USA.
Jian WangDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, USA.
Joya ChandraDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Gregory K FriedmanDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA.
Shulin LiDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, USA. Electronic address: sli4@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapseR01NS122857 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HEIMBERGER, AMY BETH, LI, SHULIN · 2021 to 2025
$2.9M
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
NCI NIH HHS P30 CA016672NCI NIH HHS R50 CA221675NINDS NIH HHS R01 NS122857
6 · The paper itself

Abstract

The failure to prevent brain tumors, including both recurrent primary and metastatic brain tumors, is the primary cause of patients' mortality. We developed a novel whole tumor-cell vaccine to rapidly induce long-duration brain-resident memory T (T

Indexed as

Brain NeoplasmsCancer VaccinesImmunologic MemoryMemory T CellsAnimalsBrainCell Line, TumorFemaleHumansMiceMice, Inbred C57BLMice, KnockoutCancer VaccinesBrain tumorsCD47Fibrinogen-like protein 2ImmunotherapyResident memory T cells

Identifiers

PMID41380903
PMCPMC13359019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.